生物活性 | |||
---|---|---|---|
描述 | Indirubin-3'-monoxime is an antagonist to GSK-3β by competing with ATP, displaying a Ki of 0.85 μM, and a Km of 110 μM. Furthermore, it deters the phosphorylation of tau by GSK-3β, showing an IC50 roughly around 100 nM, and fully obstructs the phosphorylation at the AT100 epitope[1]. Additionally, Indirubin-3'-monoxime impedes the proliferation of vascular smooth muscle cells (VSMC) with an IC50 approximately 2 µM. It mitigates the PDGF-induced migration of VSMC and hinders the migratory response in VSMCs, while also diminishing the production of pro-migratory LT in monocytes. Indirubin-3'-monoxime equally curbs the synthesis of 5-lipoxygenase (5-LO) products in monocytes and neutrophils, with IC50 values of 5.0±1.1 and 3.7±1.2 µM, respectively, and it stands as a 5-LO inhibitor with an IC50 between 7.8-10 µM in assays free of cells[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.61mL 0.72mL 0.36mL |
18.03mL 3.61mL 1.80mL |
36.06mL 7.21mL 3.61mL |
参考文献 |
---|